Pluristem therapeutics inc (PSTI)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11
CURRENT ASSETS:
Cash and cash equivalents

6,762

7,300

3,715

4,106

9,535

6,796

8,433

8,821

5,940

8,581

12,294

4,707

5,319

7,334

6,098

6,223

5,404

4,948

10,805

22,626

8,944

6,961

4,493

3,638

4,626

8,603

9,007

27,821

23

38,751

9,389

11,605

6,672

13,633

42,829

Short-term bank deposits

8,037

8,780

14,838

19,599

1,002

7,917

13,283

21,079

27,435

15,975

2,151

6,235

12,329

0

6,731

8,570

11,258

16,517

15,574

7,167

10,900

12,582

19,451

26,130

23,345

24,047

31,449

22,960

32

21,434

21,397

21,896

30,491

31,658

0

Restricted cash and short-term bank deposits

686

571

562

692

703

916

777

687

691

566

599

559

574

570

543

542

542

550

551

1,076

895

691

4,914

3,716

456

753

316

-

-

-

-

-

-

-

-

Restricted cash and restricted short term deposits

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Marketable securities

-

-

-

-

-

-

-

-

0

10,736

6,301

15,164

14,842

14,039

15,933

17,415

20,768

21,636

20,309

22,250

21,246

25,701

29,961

30,349

28,776

16,016

13,441

9,045

8

8,129

7,023

6,042

4,352

513

0

Accounts receivable from the Israeli Innovation Authority ("IIA")

-

-

-

-

285

82

37

-

596

172

25

1,036

318

287

459

2,228

180

150

419

1,691

204

158

2,263

-

-

-

273

-

-

-

-

-

-

-

-

Other current assets

2,334

2,576

2,356

1,974

1,671

2,643

1,921

1,449

1,046

1,044

1,471

1,315

1,221

723

550

618

-

-

1,152

2,058

1,501

1,040

905

876

1,198

3,049

599

-

-

-

383

-

-

-

-

Other account receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

975

981

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

172

217

334

314

Accounts receivable from the Office of the Chief Scientist

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,529

1,845

-

0

Other accounts receivable and prepaid expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,284

1

1,668

-

211

266

225

154

Total current assets

17,819

19,227

21,471

26,371

13,196

18,354

24,451

32,036

35,708

37,074

22,841

29,016

34,603

22,953

30,314

35,596

39,127

44,782

48,810

56,868

43,690

47,133

61,987

64,709

58,401

52,468

55,085

61,110

66

69,982

38,192

41,455

43,843

46,363

43,297

LONG-TERM ASSETS:
Long-term deposits and restricted bank deposits

396

409

408

398

391

379

385

383

398

403

397

403

385

364

374

363

369

340

343

360

343

271

304

316

-

-

421

-

-

-

-

-

-

-

-

Long-term deposits and restricted deposits

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

317

311

-

789

0

984

-

695

1,186

866

179

Long-term deposits and restricted deposits

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,287

-

-

-

-

Severance pay fund

607

671

688

693

872

837

858

846

888

856

817

804

725

695

748

766

770

749

758

753

674

723

901

1,220

1,135

1,020

905

775

0

571

522

525

485

459

452

Advance payment for leasehold improvements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,400

-

-

-

-

Property and equipment, net

2,777

3,067

3,372

3,838

4,265

4,723

5,186

5,678

5,955

6,367

6,851

7,277

7,825

8,287

8,773

9,216

9,719

10,170

10,400

10,173

9,729

10,202

10,823

11,125

11,449

11,663

11,866

11,501

10

6,440

5,019

3,066

2,883

2,156

2,088

Operating lease right-of-use asset

1,416

1,484

1,631

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term assets

5

2

3

10

7

10

13

17

22

33

48

34

-

-

-

0

-

-

-

1

1

9

8

18

26

21

39

113

1

3,428

0

1,155

1,245

-

0

Other long term assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

49

0

39

-

-

-

-

-

Total long-term assets

5,201

5,633

6,102

4,939

5,535

5,949

6,442

6,924

7,263

7,659

8,113

8,518

8,935

9,346

9,895

10,345

10,858

11,259

11,501

11,287

10,747

11,205

12,036

12,679

12,927

13,015

13,231

13,227

12

11,462

9,228

5,441

5,799

3,481

2,719

Total assets

23,020

24,860

27,573

31,310

18,731

24,303

30,893

38,960

42,971

44,733

30,954

37,534

43,538

32,299

40,209

45,941

49,985

56,041

60,311

68,155

54,437

58,338

74,023

77,388

71,328

65,483

68,316

74,337

79

81,444

47,420

46,896

49,642

49,844

46,016

CURRENT LIABILITIES
Trade payables

1,810

1,857

2,890

2,281

2,892

2,073

2,133

3,261

1,924

1,808

1,553

1,966

1,679

2,775

2,288

2,705

1,968

1,835

1,495

3,268

2,395

2,522

3,465

2,696

2,711

2,880

2,837

2,577

3

1,696

1,368

1,529

1,174

1,076

1,177

Accrued expenses

2,602

2,549

2,382

3,744

3,342

2,936

3,048

2,266

2,443

1,714

1,486

1,465

1,433

1,079

1,513

1,369

1,157

1,277

1,010

910

661

677

915

1,155

902

1,003

1,040

780

0

1,069

922

230

231

376

208

Operating lease liability, current

982

964

964

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

379

379

379

379

379

379

379

379

379

779

0

779

779

923

923

923

0

Advance payment from United

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

70

93

124

143

247

261

297

356

393

567

0

959

1,576

1,509

1,926

2,000

0

Other accounts payable

1,806

1,621

1,607

2,133

2,013

2,225

2,217

3,021

3,440

2,275

1,732

1,983

2,273

1,523

1,573

1,701

1,683

1,500

1,289

1,533

1,457

1,452

2,391

1,951

1,290

1,113

1,272

1,062

0

729

877

663

722

670

633

Other current liabilities

-

-

-

-

-

-

-

-

-

-

-

-

744

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current liabilities

7,200

6,991

7,843

8,158

8,247

7,234

7,398

8,548

7,807

5,797

4,771

5,414

6,129

5,377

5,374

5,775

4,808

4,612

4,243

6,183

5,016

5,173

7,397

6,442

5,579

5,731

5,921

5,765

6

5,232

5,522

4,854

4,976

5,045

2,018

LONG-TERM LIABILITIES
Deferred revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

2,373

2,468

2,562

2,657

2,847

2,941

3,036

3,131

3,226

2,921

3

3,310

3,505

3,462

3,692

3,923

0

Accrued severance pay

850

920

942

950

1,152

1,110

1,141

1,127

1,098

1,078

950

940

866

828

892

910

912

861

866

859

781

827

1,068

1,436

1,246

1,173

1,023

923

0

709

651

679

622

582

576

Other long-term liabilities

-

-

-

381

705

765

825

778

838

897

869

929

920

980

1,040

1,100

1,159

1,219

481

502

523

544

588

611

633

657

680

709

-

-

0

-

-

-

-

Operating lease liability

801

1,039

1,261

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total long-term liabilities

1,651

1,959

2,203

1,331

1,857

1,875

1,966

1,905

1,936

1,975

1,819

1,869

1,786

1,808

1,932

2,010

2,071

2,080

3,720

3,829

3,866

4,028

4,503

4,988

4,915

4,961

4,929

4,553

3

4,019

4,156

4,141

4,314

4,505

576

STOCKHOLDERS’ EQUITY
COMMITMENTS AND CONTINGENCIES

-

-

-

-

-

-

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Common stock $0.00001 par value per share: Authorized: 30,000,000 shares Issued and outstanding: 18,673,173 shares as of March 31, 2020, 15,082,852 shares as of June 30, 2019

-

-

-

-

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Additional paid-in capital

286,189

280,423

275,670

272,825

251,870

248,359

246,011

244,203

239,943

236,767

220,375

217,822

216,742

199,343

198,921

198,432

197,726

196,929

196,292

195,303

177,555

175,776

172,998

170,721

158,038

145,794

144,109

143,356

142

141,836

103,619

99,461

97,924

95,739

94,375

Accumulated deficit

-272,020

-264,513

-258,143

-251,004

-243,244

-233,166

-224,483

-215,697

-206,716

-205,185

-196,956

-189,571

-182,555

-174,691

-168,081

-161,757

-155,552

-148,349

-144,387

-138,511

-133,216

-125,990

-113,834

-107,638

-98,362

-91,657

-86,902

-79,912

-74

-69,742

-65,747

-61,612

-57,438

-55,446

-50,953

Receivables on account of shares

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

790

280

250

0

-

-

-

-

-

-

-

-

-

-

-

-

Other comprehensive income

-

-

-

-

-

-

-

-

0

5,378

944

1,999

1,435

461

2,062

1,480

931

768

442

2,140

1,496

-399

2,959

2,875

1,158

654

259

575

0

99

-130

52

-134

1

0

Total stockholders’ equity

14,169

15,910

17,527

21,821

8,627

15,194

21,529

28,507

33,228

36,961

24,364

30,251

35,623

25,114

32,903

38,156

43,106

49,349

52,348

58,143

45,555

49,137

62,123

65,958

60,834

54,791

57,466

64,019

69

72,193

37,742

37,901

40,352

40,294

43,422

Total liabilities and stockholders’ equity

23,020

24,860

27,573

31,310

18,731

24,303

30,893

38,960

42,971

44,733

30,954

37,534

43,538

32,299

40,209

45,941

49,985

56,041

60,311

68,155

54,437

58,338

74,023

77,388

71,328

65,483

68,316

74,337

79

81,444

47,420

46,896

49,642

49,844

46,016